These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J. Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947 [Abstract] [Full Text] [Related]
10. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M. APMIS Suppl; 1997 Jan; 71():1-30. PubMed ID: 9357492 [Abstract] [Full Text] [Related]
12. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. Recker R, Lappe J, Davies KM, Heaney R. J Bone Miner Res; 2004 Oct; 19(10):1628-33. PubMed ID: 15355557 [Abstract] [Full Text] [Related]
15. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro. Marie PJ, De Vernejoul MC, Lomri A. J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953 [Abstract] [Full Text] [Related]
16. Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis. Gruber HE, Ivey JL, Thompson ER, Chesnut CH, Baylink DJ. Miner Electrolyte Metab; 1986 Jan; 12(4):246-54. PubMed ID: 3762511 [Abstract] [Full Text] [Related]
17. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. J Bone Miner Res; 1990 Apr; 5(4):311-9. PubMed ID: 2343771 [Abstract] [Full Text] [Related]